Tech Company Financing Transactions

AmpliMed Funding Round

AmpliMed secured a $5 million Series B funding round on 6/16/2005. Backers included Biotech Insight Ventures, DPEC Partners and Solstice Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1730 E River Rd. 100-A
Tucson, AZ 85718
USA

Phone

(520) 529-1000

Website

www.amplimed.com

Email Address

Not Recorded

Overview

AmpliMed Corporation, a clinical-stage pharmaceutical company founded by world-renowned oncologists, has a lead compound, Amplimexon, in Phase II clinical trials, with early evidence of efficacy and low levels of toxicity.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Dorr

        

Browse more venture capital transactions:

Prev: 6/15/2005: Parallels venture capital transaction
Next: 6/16/2005: AmpliMed venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary